+

WO2000065090A3 - Sequence de genes recepteurs associes au recepteur de l'insuline pour le diagnostic de l'obesite humaine et des troubles d'origine diabetique - Google Patents

Sequence de genes recepteurs associes au recepteur de l'insuline pour le diagnostic de l'obesite humaine et des troubles d'origine diabetique Download PDF

Info

Publication number
WO2000065090A3
WO2000065090A3 PCT/US2000/010644 US0010644W WO0065090A3 WO 2000065090 A3 WO2000065090 A3 WO 2000065090A3 US 0010644 W US0010644 W US 0010644W WO 0065090 A3 WO0065090 A3 WO 0065090A3
Authority
WO
WIPO (PCT)
Prior art keywords
diagnosis
gene sequence
human obesity
diabetic disorders
receptor
Prior art date
Application number
PCT/US2000/010644
Other languages
English (en)
Other versions
WO2000065090A2 (fr
Inventor
Si Lok
Theodore E Whitmore
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Priority to AU46498/00A priority Critical patent/AU4649800A/en
Publication of WO2000065090A2 publication Critical patent/WO2000065090A2/fr
Publication of WO2000065090A3 publication Critical patent/WO2000065090A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La présente invention concerne des procédés d'identification d'anomalies, dans le chromosome humain 1q, liées aux troubles du métabolisme du glucose. La présente invention concerne également des procédés d'identification de polymorphismes dans un gène récepteur associé au récepteur de l'insuline se trouvant sur le chromosome 1q21-q24, et plus particulièrement 1q21-q23, un locus lié à une forme de diabète de type II héréditaire.
PCT/US2000/010644 1999-04-22 2000-04-19 Sequence de genes recepteurs associes au recepteur de l'insuline pour le diagnostic de l'obesite humaine et des troubles d'origine diabetique WO2000065090A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU46498/00A AU4649800A (en) 1999-04-22 2000-04-19 The insulin receptor-related receptor gene sequence for diagnosis of human obesity and diabetic disorders

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US29690699A 1999-04-22 1999-04-22
US09/296,906 1999-04-22
US33797699A 1999-06-22 1999-06-22
US09/337,976 1999-06-22

Publications (2)

Publication Number Publication Date
WO2000065090A2 WO2000065090A2 (fr) 2000-11-02
WO2000065090A3 true WO2000065090A3 (fr) 2001-10-25

Family

ID=26969879

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/010644 WO2000065090A2 (fr) 1999-04-22 2000-04-19 Sequence de genes recepteurs associes au recepteur de l'insuline pour le diagnostic de l'obesite humaine et des troubles d'origine diabetique

Country Status (2)

Country Link
AU (1) AU4649800A (fr)
WO (1) WO2000065090A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2151502A1 (fr) * 2008-07-30 2010-02-10 Lohmann Tierzucht GmbH Variations génétiques associées au comportement de becquetage chez les espèces aviaires

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000023591A2 (fr) * 1998-10-21 2000-04-27 Zymogenetics, Inc. Proteine secretee zsig49

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000023591A2 (fr) * 1998-10-21 2000-04-27 Zymogenetics, Inc. Proteine secretee zsig49

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
ELBEIN S C ET AL: "GENOME-WIDE SEARCH FOR TYPE 2 DIABETES SUSCEPTIBILITY GENES IN CAUCASIANS: EVIDENCE FOR A RECESSIVE LOCUS ON CHROMOSOME 1", DIABETES,NEW YORK, NY,US, 13 June 1998 (1998-06-13), pages 1278b, XP000906839, ISSN: 0012-1797 *
ELBEIN S.C. ET AL.: "A genome-wide search for type 2 diabetes susceptibility genes in Utah Caucasians", DIABETES, vol. 48, no. 5, May 1999 (1999-05-01), pages 1175 - 1182, XP000944793 *
HANSON R L ET AL: "AN AUTOSOMAL GENOMIC SCAN FOR LOCI LINKED TO TYPE II DIABETES MELLITUS AND BODY-MASS INDEX IN PIMA INDIANS", AMERICAN JOURNAL OF HUMAN GENETICS,US,UNIVERSITY OF CHICAGO PRESS, CHICAGO,, vol. 63, no. 4, 1998, pages 1130 - 1138, XP000909507, ISSN: 0002-9297 *
ITOH N. ET AL.: "Two truncated forms of rat insulin receptor-related receptor", J. BIOL. CHEM., vol. 268, no. 24, 25 August 1993 (1993-08-25), pages 17983 - 17986, XP002154781 *
SHIER P. AND WATT V.M.: "Primary structure of a putative receptor for a ligand of the insulin family", J. BIOL. CHEM., vol. 264, no. 25, 5 September 1989 (1989-09-05), pages 14605 - 14608, XP002154780 *
SHIER P. ET AL.: "Localization of the insulin receptor-related receptor gene on human chromosome 1", CYTOGENET CELL GENET, vol. 54, 1990, pages 80 - 81, XP000944567 *
WHITMORE T.E. ET AL.: "The assignment of the human insulin receptor-related receptor gene (INSRR) tp chromosome 1q21-q23 by the use of radiation hybrid mapping", CYTOGENET CELL GENET, vol. 87, no. 1-2, 1999, pages 93 - 94, XP000944566 *

Also Published As

Publication number Publication date
AU4649800A (en) 2000-11-10
WO2000065090A2 (fr) 2000-11-02

Similar Documents

Publication Publication Date Title
Tan et al. Association of resistin gene 3′-untranslated region+ 62G→ A polymorphism with type 2 diabetes and hypertension in a Chinese population
Park et al. Polymorphisms in the leptin receptor (LEPR)—putative association with obesity and T2DM
WO2006063704A3 (fr) Polymorphisme a simple nucleotide (snp)
Ruegsegger et al. Running from disease: molecular mechanisms associating dopamine and leptin signaling in the brain with physical inactivity, obesity, and type 2 diabetes
WO2003038123A3 (fr) Procede de traitement du diabete et conditions apparentees basees sur des polymorphismes dans le gene tcf1
WO2004052284A3 (fr) Traitement de diabetes
WO2007038670A3 (fr) Troubles de la regulation de la glycemie :methodes et depistage et traitement
Suzuki et al. α2b-Adrenergic receptor deletion polymorphism associates with autonomic nervous system activity in young healthy Japanese
WO2006004574A3 (fr) Methode d'utilisation de gamma cyclodextrine dans la regulation de la glycemie et de la secretion d'insuline
Østergård et al. Influence of the PPAR-γ2 Pro12Ala and ACE I/D polymorphisms on insulin sensitivity and training effects in healthy offspring of type 2 diabetic subjects
WO2002072604A3 (fr) Genes et polymorphismes associes a une maladie cardiovasculaire et leur utilisation
Valenti et al. Effect of iron depletion in patients with nonalcoholic fatty liver disease without carbohydrate intolerance
Dirkali et al. The impact of admission plasma glucose on long-term mortality after STEMI and NSTEMI myocardial infarction
EP1871894A4 (fr) Combinaison de dosage du 1,5-anhydroglucitol (1,5-ag) et de dosage du a1c/1,5-ag pour la mesure des variations de la glycemie dans le cas d'hyperglycemie generale et post-prandiale chez des patients diabetiques
WO2000065090A3 (fr) Sequence de genes recepteurs associes au recepteur de l'insuline pour le diagnostic de l'obesite humaine et des troubles d'origine diabetique
Albala et al. FABP2 Ala54Thr polymorphism and diabetes in Chilean elders
Fritsche et al. The prevalent Gly1057Asp polymorphism in the insulin receptor substrate-2 gene is not associated with impaired insulin secretion
WO2008065544A3 (fr) Prédicteurs génétiques d'un risque de diabète sucré de type 2
WO2001004349A3 (fr) Diagnostic ou pronostic de la maladie d'alzheimer et composition therapeutique pour la prevention ou le traitement de la maladie d'alzheimer
Al-Ashoor et al. Analysis of OCT1, OCT2 and OCT3 gene polymorphisms among Type 2 diabetes mellitus subjects in Indian ethnicity, Malaysia
WO2006063703A8 (fr) Polymorphisme a simple nucleotide (snp)
Fischer et al. KCNJ11 E23K affects diabetes risk and is associated with the disposition index: results of two independent German cohorts
Dorsey-Trevino et al. Association of GLP1R polymorphisms with the incretin response
WO2004042358A3 (fr) Gene slit-3 du diabete de type ii humain situe sur le chromosome 5q35
Buraczynska et al. Leu72Met polymorphism in ghrelin gene: a potential risk factor for hypertension in type 2 diabetes patients

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载